248 related articles for article (PubMed ID: 31194887)
1. The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipients.
Jorgenson MR; Descourouez JL; Lyu B; Astor BC; Garg N; Smith JA; Mandelbrot DA
Clin Transplant; 2019 Aug; 33(8):e13636. PubMed ID: 31194887
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis.
Leeaphorn N; Garg N; Thamcharoen N; Khankin EV; Cardarelli F; Pavlakis M
Am J Transplant; 2019 Feb; 19(2):573-584. PubMed ID: 30431703
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy.
Felipe C; Ferreira AN; de Paula M; Viana L; Cristelli M; Medina Pestana J; Tedesco-Silva H
Transpl Infect Dis; 2019 Dec; 21(6):e13106. PubMed ID: 31081566
[TBL] [Abstract][Full Text] [Related]
4. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis.
Chaiyapak T; Borges K; Williams A; Banh T; Vasilevska-Ristovska J; Allen U; Parekh RS; Hébert D
Transplantation; 2018 Aug; 102(8):1391-1396. PubMed ID: 29377877
[TBL] [Abstract][Full Text] [Related]
6. Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes.
Jorgenson MR; Descourouez JL; Cardinale B; Lyu B; Astor BC; Garg N; Saddler CM; Smith JA; Mandelbrot DA
Transpl Infect Dis; 2019 Jun; 21(3):e13080. PubMed ID: 30891915
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.
Jaamei N; Koutsokera A; Pasquier J; Mombelli M; Meylan P; Pascual M; Aubert JD; Manuel O
Transpl Infect Dis; 2018 Aug; 20(4):e12893. PubMed ID: 29603543
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease.
Reusing JO; Feitosa EB; Agena F; Pierrotti LC; Azevedo LSF; Kotton CN; David-Neto E
Transpl Infect Dis; 2018 Oct; 20(5):e12929. PubMed ID: 29809309
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy.
Werzowa J; Schwaiger B; Hecking M; Strassl R; Schmaldienst S; Böhmig GA; Genser B; Säemann MD
Clin Transplant; 2015 Dec; 29(12):1230-8. PubMed ID: 26458731
[TBL] [Abstract][Full Text] [Related]
10. Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies.
Erdbruegger U; Scheffner I; Mengel M; Schwarz A; Verhagen W; Haller H; Gwinner W
Nephrol Dial Transplant; 2012 Jan; 27(1):435-43. PubMed ID: 21712490
[TBL] [Abstract][Full Text] [Related]
11. Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study.
Monforte V; Sintes H; López-Gallo C; Delgado M; Santos F; Zurbano F; Solé A; Gavaldá J; Borro JM; Redel-Montero J; Cifrian JM; Pastor A; Román A; Ussetti P
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28294487
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage.
Santos CA; Brennan DC; Saeed MJ; Fraser VJ; Olsen MA
Clin Transplant; 2016 Apr; 30(4):435-44. PubMed ID: 26841129
[TBL] [Abstract][Full Text] [Related]
13. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.
Arthurs SK; Eid AJ; Pedersen RA; Kremers WK; Cosio FG; Patel R; Razonable RR
Clin Infect Dis; 2008 Mar; 46(6):840-6. PubMed ID: 18260785
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
16. Use of mTOR inhibitor as prophylaxis for cytomegalovirus disease after kidney transplantation: A natural experiment.
Cristelli MP; Felipe CR; Prizmic PSS; de Azevedo VFD; Viana LA; Tavares MG; Wagner de Castro Lima Santos D; de Paula MI; Medina-Pestana JO; Tedesco-Silva Junior H
Clin Transplant; 2019 Oct; 33(10):e13689. PubMed ID: 31400155
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience.
Sund F; Tufveson G; Döhler B; Opelz G; Eriksson BM
Nephrol Dial Transplant; 2013 Mar; 28(3):758-65. PubMed ID: 23243043
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection and graft rejection in renal transplantation.
Dickenmann MJ; Cathomas G; Steiger J; Mihatsch MJ; Thiel G; Tamm M
Transplantation; 2001 Mar; 71(6):764-7. PubMed ID: 11330539
[TBL] [Abstract][Full Text] [Related]
19. Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients.
Heldenbrand S; Li C; Cross RP; DePiero KA; Dick TB; Ferguson K; Kim M; Newkirk E; Park JM; Sudaria-Kerr J; Tichy EM; Ueda KR; Weng R; Wisniewski J; Gabardi S
Transpl Infect Dis; 2016 Dec; 18(6):904-912. PubMed ID: 27639246
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.
Yadav SK; Saigal S; Choudhary NS; Saha S; Sah JK; Saraf N; Kumar N; Goja S; Rastogi A; Bhangui P; Soin AS
Transpl Infect Dis; 2018 Aug; 20(4):e12905. PubMed ID: 29668120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]